Interestingly, by using epigenetic agents (azacytidine—DNA demethylation agent and trichostatin A—histone deacetylation inhibitor), it was found that CYP2A13 expression is induced in NCI-H441 human lung cancer cells [81] (Figure 1). Here, CYP2A13 is linked to lung cancer.